Fjarde AP Fonden Fourth Swedish National Pension Fund Has $13.02 Million Position in Xylem Inc. $XYL

Fjarde AP Fonden Fourth Swedish National Pension Fund grew its stake in Xylem Inc. (NYSE:XYL) by 69.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 108,939 shares of the industrial products company’s stock after purchasing an additional 44,600 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Xylem were worth $13,018,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in XYL. Callahan Advisors LLC bought a new position in shares of Xylem during the fourth quarter worth approximately $1,721,000. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Xylem by 2,309.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 431,824 shares of the industrial products company’s stock worth $54,314,000 after buying an additional 413,904 shares in the last quarter. Abacus Wealth Partners LLC acquired a new position in Xylem during the fourth quarter worth about $1,663,000. Boston Common Asset Management LLC boosted its position in Xylem by 15.3% in the fourth quarter. Boston Common Asset Management LLC now owns 143,740 shares of the industrial products company’s stock valued at $19,575,000 after buying an additional 19,073 shares in the last quarter. Finally, Norges Bank bought a new stake in Xylem during the 4th quarter worth $361,012,000. Institutional investors own 87.96% of the company’s stock.

Xylem Stock Performance

Shares of Xylem stock opened at $118.22 on Friday. The business’s fifty day simple moving average is $112.66 and its 200 day simple moving average is $124.67. The firm has a market capitalization of $28.10 billion, a P/E ratio of 29.41, a price-to-earnings-growth ratio of 1.68 and a beta of 1.03. Xylem Inc. has a 12 month low of $105.29 and a 12 month high of $154.27. The company has a current ratio of 1.46, a quick ratio of 1.10 and a debt-to-equity ratio of 0.13.

Xylem (NYSE:XYL) last released its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.09 by $0.03. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The firm had revenue of $2.12 billion for the quarter, compared to analysts’ expectations of $2.11 billion. During the same period in the previous year, the company earned $1.03 earnings per share. The company’s quarterly revenue was up 2.7% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, analysts anticipate that Xylem Inc. will post 5.51 EPS for the current year.

Xylem Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were paid a $0.43 dividend. The ex-dividend date was Thursday, May 28th. This represents a $1.72 annualized dividend and a dividend yield of 1.5%. Xylem’s dividend payout ratio (DPR) is presently 42.79%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on XYL shares. Jefferies Financial Group raised shares of Xylem from a “hold” rating to a “buy” rating and boosted their target price for the stock from $130.00 to $140.00 in a report on Thursday, June 25th. JPMorgan Chase & Co. lowered their target price on Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday, April 16th. Stifel Nicolaus decreased their price target on shares of Xylem from $163.00 to $159.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. CLSA raised Xylem to a “hold” rating in a research report on Thursday, June 25th. Finally, Barclays lowered their target price on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a report on Wednesday, April 29th. Eight equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, Xylem presently has an average rating of “Moderate Buy” and an average target price of $153.54.

Insider Buying and Selling

In related news, Director Jerome A. Peribere purchased 1,210 shares of the firm’s stock in a transaction dated Monday, May 4th. The shares were purchased at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the transaction, the director directly owned 27,209 shares in the company, valued at approximately $3,172,841.49. This represents a 4.65% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the sale, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. This trade represents a 54.22% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.32% of the stock is currently owned by insiders.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.